Wang, Jianxiang http://orcid.org/0000-0001-9437-9151
Jiang, Bin
Li, Jian http://orcid.org/0000-0002-4549-0694
Liu, Ligen
Du, Xin
Jiang, Hao
Hu, Jianda http://orcid.org/0000-0002-4438-2544
Yuan, Menghe
Sakatani, Taishi http://orcid.org/0000-0001-9585-3855
Kadokura, Takeshi
Takeuchi, Masato
Kosako, Masanori http://orcid.org/0000-0002-4981-9450
Ma, Xiao
Girshova, Larisa http://orcid.org/0000-0002-0559-9556
Tan, Jerome
Bondarenko, Sergey
Lee, Lily Wong Lee
Khuhapinant, Archrob
Martynova, Elena
Hasabou, Nahla
Funding for this research was provided by:
Astellas Pharma US (n/a, n/a, n/a, n/a, n/a, n/a, n/a, n/a, n/a, n/a, n/a, n/a, n/a, n/a, n/a, n/a, n/a, n/a, n/a, n/a)
Article History
Received: 18 March 2024
Revised: 10 July 2024
Accepted: 13 August 2024
First Online: 5 September 2024
Competing interests
: MY, TS, TK, MT, MK, XM, and NH are all employees of Astellas. TS reports Astellas stocks. BJ, JL, LL, XD, HJ, LG, JT, LWLL, AK, and EM report consulting and honoraria fees from Astellas. JW, JH, and SB have nothing to disclose.